ArticleTherapeutics and clinical risk management2018

Effect of denosumab on bone mineral density in Japanese women with osteopenia treated with aromatase inhibitors for breast cancer: subgroup analyses of a Phase II study.

Katsuhiko Nakatsukasa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.